MedPath

Uroxatral

UROXATRAL (alfuzosin hydrochloride) tablet, extended release

Approved
Approval ID

0fb9f3ab-45d1-405e-a14e-4cb4b1a28c55

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Oct 27, 2009

Manufacturers
FDA

Stat Rx USA

DUNS: 786036330

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Alfuzosin Hydrochloride

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code16590-279
Application NumberNDA021287
Product Classification
M
Marketing Category
C73594
G
Generic Name
Alfuzosin Hydrochloride
Product Specifications
Route of AdministrationORAL
Effective DateOctober 27, 2009
FDA Product Classification

INGREDIENTS (1)

Alfuzosin HydrochlorideActive
Quantity: 10 mg in 1 1
Code: 75046A1XTN
Classification: ACTIB

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Uroxatral - FDA Drug Approval Details